📰 Path Inc News
Page 5 - Path Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Path Inc. Real-time updates on events, politics, business and more.
February 1, 2024
Prosperity Wealth Management Inc. boosted its holdings in shares of UiPath Inc. (NYSE:PATH – Free Report) by 8.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 14,350 shares of the healthcare company’s stock after buying an additional 1,170 shares during the period. Prosperity Wealth Management […]
January 24, 2024
UiPath Inc. (NYSE:PATH – Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $22.23, but opened at $23.25. UiPath shares last traded at $23.44, with a volume of 1,968,031 shares trading hands. Analyst Ratings Changes PATH has been the subject of a number of analyst reports. Canaccord […]
January 3, 2024
300+ Jobs Available at Bucks County New Year Job Fair - The career fair will be held at Barnes & Noble Court at Neshaminy Mall on Jan. 17.
January 1, 2024
UiPath Inc. (NYSE:PATH – Get Free Report)’s share price traded down 34.1% during mid-day trading on Thursday after Canaccord Genuity Group lowered their price target on the stock from $30.00 to $19.00. Canaccord Genuity Group currently has a buy rating on the stock. UiPath traded as low as $11.81 and last traded at $12.06. 39,985,258 […]
January 1, 2024
UiPath (NYSE:PATH – Get Free Report) was downgraded by research analysts at William Blair from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Thursday, Marketbeat.com reports. Other equities analysts have also issued research reports about the stock. Barclays upped their price objective on shares of […]
January 1, 2024
UiPath (NYSE:PATH – Get Free Report) was downgraded by analysts at William Blair from an “outperform” rating to a “market perform” rating in a research report issued on Thursday, MarketBeat reports. A number of other analysts have also recently issued reports on the company. Barclays lifted their price objective on UiPath from $23.00 to $25.00 […]
January 1, 2024
UiPath (NYSE:PATH – Get Free Report)‘s stock had its “hold” rating reaffirmed by Truist Financial in a report issued on Thursday, MarketBeat.com reports. They presently have a $14.00 target price on the healthcare company’s stock, down from their previous target price of $32.00. Truist Financial’s target price would indicate a potential upside of 14.19% from […]
January 1, 2024
UiPath (NYSE:PATH – Get Free Report)‘s stock had its “hold” rating reaffirmed by investment analysts at Needham & Company LLC in a report issued on Thursday, MarketBeat Ratings reports. Other research analysts have also recently issued research reports about the company. JPMorgan Chase & Co. raised UiPath from a “neutral” rating to an “overweight” rating […]
December 26, 2023
DnB Asset Management AS reduced its position in UiPath Inc. (NYSE:PATH – Free Report) by 9.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 105,998 shares of the healthcare company’s stock after selling 11,311 shares during the period. DnB Asset Management AS’s holdings in UiPath were worth […]